热门资讯> 正文

USANA Health Sciences shares fall on prelim Q3 results

2025-10-10 04:19

USANA Health Sciences (NYSE:USNA) announced on Thursday preliminary results for the third quarter ended September 27, 2025.
The company anticipates third quarter 2025 net sales will be approximately $214M, which compares with $200M in the prior-year period.
Earnings from operations are expected to be $1.2M for the current-year quarter, or 0.6% of net sales, as compared to $15.6M in the third quarter of 2024.
The company is providing preliminary consolidated third quarter results as follows:

	Q3 2025 Preliminary Results	Q3 2024
Net sales	$214 million	$200 million
Effective income tax rate	471%	43%
Net (loss) earnings	($6.5) million	$10.6 million
Diluted EPS	($0.36)	$0.56
Adjusted Diluted EPS	($0.15)	$0.56
Adjusted EBITDA	$13.8 million	$24.6 million

USANA Health Sciences (NYSE:USNA) shares were down more than 9% in extended trading.

More on USANA Health Sciences

USANA Health Sciences: Hiya's Potential Is Showing
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript
Usana signals major compensation plan overhaul and product launches while repaying debt and achieving 11% sales growth
USANA Health Sciences Non-GAAP EPS of $0.74 beats by $0.20, revenue of $236M beats by $10.81M
Seeking Alpha’s Quant Rating on USANA Health Sciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。